Package 65862-841-30

{"route": ["ORAL"], "spl_id": "81e4395b-8a3e-466e-b039-0a804f171b43", "openfda": {"upc": ["0365862841308"], "unii": ["5968Y6H45M"], "rxcui": ["485434", "485436"], "spl_set_id": ["def332bf-2906-4a6c-b85d-dfb56bb94312"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (65862-841-30)  / 30 TABLET in 1 BOTTLE", "package_ndc": "65862-841-30", "marketing_start_date": "20150826"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (65862-841-90)  / 90 TABLET in 1 BOTTLE", "package_ndc": "65862-841-90", "marketing_start_date": "20150826"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (65862-841-99)  / 1000 TABLET in 1 BOTTLE", "package_ndc": "65862-841-99", "marketing_start_date": "20150826"}], "brand_name": "Entecavir", "product_id": "65862-841_81e4395b-8a3e-466e-b039-0a804f171b43", "dosage_form": "TABLET", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Analog [EXT]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "65862-841", "generic_name": "Entecavir", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Entecavir", "active_ingredients": [{"name": "ENTECAVIR", "strength": ".5 mg/1"}], "application_number": "ANDA206217", "marketing_category": "ANDA", "marketing_start_date": "20150826", "listing_expiration_date": "20261231"}